Study Links Weight-Loss Injections to Eye Condition Leading to Blindness

A recent study has found a concerning link between weight-loss injections and the development of an eye condition that can lead to blindness. Individuals with diabetes prescribed semaglutide were over four times more likely to develop non-arteritic anterior ischemic optic neuropathy (naion). The research, conducted by Harvard University, analyzed data from over 16,000 patients and revealed a significantly higher incidence of naion in those on semaglutide compared to other medications.